Home › Stocks › APVO

Aptevo Therapeutics Inc. (APVO): insider buying, hedge funds & Congress trades

Aptevo Therapeutics Inc. (APVO): 1 insider purchase in the last two years; 1 trade disclosed by members of Congress.

Insider buying

FiledInsiderSharesPriceValueType
Nov 12, 2025Grant Grady III
Director
13,513$1.49$20.1Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for APVO

Free account. Know when insiders, famous funds or Congress trade it.

Start free

Congress trades in APVO

FiledMemberTypeAmount
Jul 3, 2019Steve Cohensale$470.99 g